    <SEC-DOCUMENT>0001104659-25-048564-index.html : 20250514
    <SEC-HEADER>0001104659-25-048564.hdr.sgml : 20250514
    <ACCEPTANCE-DATETIME>20250514163954
    ACCESSION NUMBER:		0001104659-25-048564
    CONFORMED SUBMISSION TYPE:	424B3
    PUBLIC DOCUMENT COUNT:		21
    FILED AS OF DATE:		20250514
    DATE AS OF CHANGE:		20250514

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			GLYCOMIMETICS INC
    		CENTRAL INDEX KEY:			0001253689
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				000000000
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		424B3
    		SEC ACT:		1933 Act
    		SEC FILE NUMBER:	333-285035
    		FILM NUMBER:		25946512

    	BUSINESS ADDRESS:
    		STREET 1:		9708 MEDICAL CENTER DRIVE
    		CITY:			ROCKVILLE
    		STATE:			MD
    		ZIP:			20850
    		BUSINESS PHONE:		240-243-1201

    	MAIL ADDRESS:
    		STREET 1:		9708 MEDICAL CENTER DRIVE
    		CITY:			ROCKVILLE
    		STATE:			MD
    		ZIP:			20850
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>424B3
    <SEQUENCE>1
    <FILENAME>tm256615-16_424b3.htm
    <DESCRIPTION>424B3
    <TEXT>
    Document 1 - file: tm256615-16_424b3.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>lg_glycomimetics-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 2 - file: lg_glycomimetics-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>lg_crescent-4clr.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 3 - file: lg_crescent-4clr.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>bc_paidvstsr-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: bc_paidvstsr-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>5
    <FILENAME>bc_paidvsnetincome-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 5 - file: bc_paidvsnetincome-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>6
    <FILENAME>bc_inhibitors-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 6 - file: bc_inhibitors-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>7
    <FILENAME>lc_nsclc-4clr.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 7 - file: lc_nsclc-4clr.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>8
    <FILENAME>tb_pfs-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 8 - file: tb_pfs-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>9
    <FILENAME>ph_vegf-4clr.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 9 - file: ph_vegf-4clr.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>10
    <FILENAME>ph_cr001-4clr.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 10 - file: ph_cr001-4clr.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>11
    <FILENAME>lc_cooperative-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 11 - file: lc_cooperative-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>12
    <FILENAME>ph_antivegf-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 12 - file: ph_antivegf-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>13
    <FILENAME>tb_clinicaldevelop-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 13 - file: tb_clinicaldevelop-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>14
    <FILENAME>fc_chemotherapy-4clr.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 14 - file: fc_chemotherapy-4clr.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>15
    <FILENAME>fc_cr002adc-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 15 - file: fc_cr002adc-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>16
    <FILENAME>lg_lucidcapital-bwlr.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 16 - file: lg_lucidcapital-bwlr.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>17
    <FILENAME>ft_lucidcapnewyork-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 17 - file: ft_lucidcapnewyork-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>18
    <FILENAME>sg_lucidcapitalmarkets-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 18 - file: sg_lucidcapitalmarkets-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>19
    <FILENAME>lg_walkers-bwlr.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 19 - file: lg_walkers-bwlr.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>20
    <FILENAME>px_glycoproxy1pg01-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 20 - file: px_glycoproxy1pg01-bw.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>21
    <FILENAME>px_glycoproxy1pg02-bw.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 21 - file: px_glycoproxy1pg02-bw.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>